GlobeNewswire

Skybox Security Wins SC Awards’ Best Risk and Security Policy Management

Del

Skybox takes home the SC US Award for Best Risk and Security Policy Management Solution for the second year in a row

SAN JOSE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Skybox® Security, a global leader in cyber risk management, won the Trust Award for Best Risk and Security Policy Management for the second year in a row at the 2019 SC US Awards. The announcement was made Tuesday, March 5, 2019, during the 23rd annual SC Awards gala in San Francisco, presented by SC Media.

The Skybox® Security Suite has been designed to help the most complex, security-conscious enterprises to bridge security management gaps within their organizations, intelligently automating processes to support risk reduction and compliance management. This second Trust Award win in the Best Risk and Security Policy Management category is the latest in a string of accolades awarded to the platform, including being named in CRN’s 2019 Security 100 List and JMP Securities’ 70 Hottest Privately Held Companies, as well as Cyber Defense Magazine’s InfoSec Award for Best Vulnerability Management Product.

“Our second successive win at the SC Awards reaffirms the strength of Skybox Security’s solution,” said Gidi Cohen, CEO and founder of Skybox. “Today’s security leaders face an almost impossible task to control risk in mass-scale, highly complex and hybrid IT and cloud environments, all while demonstrating continuous compliance amid rapid change. At Skybox, we recognize the importance of simplifying risk and security policy management and are dedicated to bringing about positive and enduring change to this field. The second Trust Award win shows that our approach resonates with thought leaders as well as practitioners.”

In SC Media’s announcement of the win, they remarked, “Companies are always looking for new and better vantage points from which they can view and manage network risk. And in that sense, Skybox Security offers the best seat in the house."

Skybox Security’s second win in this category comes after it ended 2018 with its best quarter ever, exceeding its previous record by 62 percent. 

“Faced with a growing skills crisis and mounting complexity, CISOs need a solution which gives them visibility of their entire environment, as well as the context needed to focus teams on their biggest risks,” said Executive Vice President of Sales Stewart Fox. “That’s what Skybox does. Record sales, strong win and retention rates, as well as accolades like this Trust Award — all demonstrate that we’re right to be confident in our solution.”

The SC Awards are recognized throughout the security industry as the gold standard of excellence in cybersecurity. Winners of the Trust Award for Best Risk and Policy Management were chosen by a distinguished group of leading IT security professionals from SC Media's readership and selected by SC Media’s editorial team.

“When choosing winners for our Trust Awards, SC Media considered such factors as functionality, innovativeness, scalability, ease of use, cost of ownership, return on investment, and customer friendliness,” said Illena Armstrong, vice president of editorial at SC Media. “Across these facets, Skybox Security highly impressed our judges.”

About Skybox Security

www.skyboxsecurity.com

Skybox provides the industry’s broadest cybersecurity management platform to address security challenges within large, complex networks. By integrating with 120 networking and security technologies, the Skybox® Security Suite gives comprehensive attack surface visibility and the context needed for informed action. Our analytics, automation and intelligence improve the efficiency and performance of security operations in vulnerability and threat management and firewall and security policy management for the world’s largest organizations.

© 2019 Skybox Security, Inc. All rights reserved. Skybox Security and the Skybox Security logo are either registered trademarks or trademarks of Skybox Security, Inc., in the United States and/or other countries. All other trademarks are the property of their respective owners. Product specifications subject to change at any time without prior notice.

Tweet This: The Best #CyberRisk and #PolicyManagement Solution for the second year in a row. See why @SkyboxSecurity kept its crown at the @SCMagazine awards: http://ow.ly/ikNY30o0szD

CONTACT INFORMATION

Victoria Davis Schmidt
Corporate Communications for Skybox Security
571.340.0181 | Victoria.Schmidt@skyboxsecurity.com

OneChocolate for Skybox Security
United Kingdom: Daniel Couzens
+44 (0)20 7437 0227 | DanielC@onechocolatecomms.co.uk

Germany: Stephanie Thoma
+49 (0)89 388 892 012 | Stephaniet@onechocolatecomms.de

France: Xavier Delhôme
+33 1 41 31 75 09 | xavier@onechocolate.fr

Alliance Public Relations Pvt. Ltd.
India: Meenakshi Lenka
+91-9810577773 | meenakshi@proalliancepr.co

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CETPressemelding

Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CETPressemelding

German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored

NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in

Standard Lithium Announces Closing of $11.4 Million Bought Deal Including Partial Exercise of Over-Allotment Option21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L) is pleased to announce that it has closed its previously announced bought deal offering (the “Offering”), including the partial exercise of the over-allotment option. A total of 11,390,500 units (the “Units”) of the Company were issued at a price of $1.00 per Unit for gross proceeds of $11,390,500. Each Unit is comprised of one common share and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company at an exercise price of $1.30 per share, subject to adjustment in certain events, until March 21, 2022. The Units were offered and sold by way of a short form prospectus filed in each of the provinces of ‎Canada, excluding Quebec, and offered and sold elsewhere outside of Canada on a private placement

Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 201921.3.2019 13:30:00 CETPressemelding

15 posters present data from novel models to evaluate new cancer therapeutics SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the presentation of 15 scientific posters at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA from March 29 to April 3. The scientific posters highlight the latest advancements in CrownBio’s integrated oncology and immuno-oncology platforms built on the world’s largest and unique experimental model libraries, including patient-derived xenografts (PDXs), innovative humanized mouse models, GEMM, syngeneic mouse tumor homografts, PDX derived organoids (PDXO), and uniquely developed analytic methods. Featured posters will present data from novel models that enable detailed evaluation of new cancer therapeutics, including targeted cancer i

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease21.3.2019 12:00:00 CETPressemelding

Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced the decision to discontinue the global Phase 3 trials, ENGAGE and EMERGE, designed to evaluate the efficacy and safety of aducanumab in patients with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease dementia. The decision to stop the trials is based on results of a futility analysis conducted by an independent data monitoring committee, which indicated the trials were unlikely to meet their primary endpoint upon completion. The recommendation to stop the studies was not based on safety concerns. “This disappointing news confirms the complexity of treating Alzheimer’s disease and the need to further advance knowledge in neuroscience. We are incredibly grateful to all the Alzheimer’s disease pa